Stockscreener 앱 받기
1.47
0.68%
0.01
시간 외 거래:
1.45
-0.02
-1.36%
전일 마감가:
$1.46
열려 있는:
$1.45
하루 거래량:
25,257
Relative Volume:
0.25
시가총액:
$2.14M
수익:
$2,000
순이익/손실:
$-12.72M
주가수익비율:
-0.0205
EPS:
-71.8121
순현금흐름:
$-3.91M
1주 성능:
+12.21%
1개월 성능:
-20.54%
6개월 성능:
-67.73%
1년 성능:
+0.00%
1일 변동 폭
$1.37
$1.52
1주일 범위
$1.1401
$1.66
52주 변동 폭
$1.1401
$23.80
Nexentis Technologies Inc Stock (NXTS) Company Profile
명칭
Nexentis Technologies Inc
전화
972544561349
주소
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, MOS, ICL
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
1.47 | 2.14M | 2,000 | -12.72M | -3.91M | -71.81 |
CTVA
Corteva Inc
|
78.52 | 52.39B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
72.23 | 34.47B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
114.67 | 17.35B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
23.01 | 7.31B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.14 | 6.63B | 7.41B | 314.00M | 220.88M | 0.202 |
Nexentis Technologies Inc 주식(NXTS)의 최신 뉴스
Nexentis Technologies Inc. (NXTS) stock price, news, quote and history - Yahoo Finance UK
Nexentis Technologies Inc. (NXTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nexentis appoints computational chemistry expert to advisory board - Investing.com
Nexentis appoints computational chemistry expert to advisory board By Investing.com - Investing.com Nigeria
Nexentis Technologies Announces Appointment of Prof. Dan T. Major to MitoCareX Scientific Advisory Board - Quiver Quantitative
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board - GlobeNewswire Inc.
Nexentis subsidiary evaluates ways for obtaining proteins in in-vitro research - TipRanks
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery - The Manila Times
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities - GlobeNewswire
Nexentis Technologies Inc. (NASDAQ: NXTS) Share Price, NXTS Stock News, NXTS Share Price & Updates - kalkine.com.au
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
NXTS Q2 2025 Earnings: Reported Per-Share Loss of $0.18 as Stock Edges Up 1.2%Earnings Weakness Phase - dars.gov.et
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Faces Nasdaq Delisting Over Equity Shortfall - Minichart
Nexentis Technologies Faces Nasdaq Compliance and Delisting Risk - TipRanks
Nexentis Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NXTS - Finviz
Nexentis Technologies Inc. (NXTS) Rises 5.98% to $1.95, Approaching Key Resistance at $2.05Hedge Fund Favorites - Vinanet
Nexentis Technologies (NXTS) flags going concern after $17.7M loss and $6.3M impairment - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexentis Technologies (NASDAQ: NXTS) changes auditors after prior going concern note - Stock Titan
Nexentis Technologies (NXTS) Gains 4% as Bullish Momentum Builds Toward Key $2.03 ResistanceIchimoku Entry - dars.gov.et
NXTS Q2 2025 Earnings: Loss of $0.18 Per Share Reported as Stock Climbs 10.32%Analyst Earnings Estimate - vinanet.vn
NXTS Q2 2025 Earnings: Reported Loss of -$0.18 Per Share, Yet Shares Jump 10.32%Financial Health Score - vinanet.vn
Nexentis subsidiary selects candidate for drug discovery program By Investing.com - Investing.com Canada
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - globenewswire.com
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing ChallengesNegative Surprise Momentum - dars.gov.et
Nexentis Technologies Inc. Revenue Breakdown – NASDAQ:NXTS - TradingView
Nexentis Technologies (NXTS) Drops 7%: Key Support Level in FocusStraddle Setup - dars.gov.et
NXTS Q2 2025 Earnings: Wider-than-expected loss drives shares down 7.86%Return On Capital - careplusvn.com
Nexentis Technologies Inc. SEC Filing (Jul 20, 2026) - Stock Titan
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffAnalyst Drop Coverage - dars.gov.et
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Inc. SEC Filing (Jul 16, 2026) - Stock Titan
Eun Young Lee holds 3.23% of Nexentis Technologies Inc. (NXTS) - Stock Titan
NXTS Q2 2025 Earnings: Wider-Than-Expected Loss Sends Shares LowerMargin Compression Risk - vinanet.vn
Nexentis Technologies files prospectus for 2.573M shares - scanx.trade
Nexentis Technologies (NASDAQ: NXTS) refreshes $100M shelf and details MitoCareX deal - Stock Titan
Nexentis Technologies registers to sell 2.57M shares of common stock for holders - TipRanks
Nexentis Technologies (NASDAQ: NXTS) registers 2.57M warrant shares for resale - Stock Titan
Nexentis Technologies Q2 2025 Earnings: Loss of -$0.18 Per Share Sends Stock Down 14.56%Negative Surprise Momentum - careplusvn.com
Nexentis Technologies (NXTS) Slides 4.5% as Selling Pressure Tests Key Support at $3.46Double EMA - dars.gov.et
NXTS Q2 2025 Earnings: Net Loss of $0.18 Per Share as Stock Slips 3.6%Earnings Quality Score - dars.gov.et
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - The Manila Times
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter - GlobeNewswire
Nexentis Technologies Shares Gain 10% on Partial Monetisation of German Solar ProjectPreliminary Results - Vinanet
Nexentis stock jumps on solar project monetization deal - Investing.com
Nexentis Announces Monetization of Part of It - Moomoo
NXTS Q2 2025 Earnings: A Disappointing Quarter as Losses Widen and Shares TumbleEarnings Yield Spread - dars.gov.et
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) - Yahoo Finance
Nexentis Technologies announces monetization of Melz solar investment - TipRanks
Nexentis Technologies Inc (NXTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.72%
5.02%
자본화:
|
볼륨(24시간):